Thrive Wealth Management, LLC

SEC CIK: 0001847610
Latest filing: Jul 7, 2026

SEC filings (opens in a new tab)

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Thrive Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overview All 13F holders of IBRX Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2025

Holdings of IBRX by Thrive Wealth Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−15,041−100.0%	Sold out	Holders
Q2 2025	15,041	$39.7K	<0.1%	+4,964+49.3%	Added	Holders
Q1 2025	10,077	$30.3K	<0.1%	+10,077	New	Holders